Lyndsay Harris, M.D.
Lyndsay Harris is an internationally recognized expert on breast cancer research and treatment where she has focused on translating findings from the laboratory to the clinic. She has worked in the field of biomarkers of breast cancer for over 25 years and has studied mechanisms of resistance to both chemo- and targeted therapy. She has published over 130 papers, chapters and reviews and participated in grant reviews through the Department of Defense, Komen and NIH. More recently her work has applied genomic technologies to understand resistance to treatment in vivo using tissue biopsies from clinical trials. She is the Program Director for Breast Cancer in the Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.